RAYZEBIO
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.
RAYZEBIO
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.rayzebio.com
Total Employee:
11+
Status:
Active
Contact:
(858) 257-3421
Total Funding:
258 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache Wordpress Plugins
Similar Organizations
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Board_member
2020-12-01
Board_member
2020-02-01
Board_member
2020-08-01
Board_member
2020-08-01
Board_observer
Current Employees Featured
Aron Knickerbocker Co-Founder @ RayzeBio
Co-Founder
2019-09-01
Susan Moran Chief Medical Officer @ RayzeBio
Chief Medical Officer
2021-07-01
Kimberly Ma SVP of Clinical Operations @ RayzeBio
SVP of Clinical Operations
2021-07-01
Ken Song President & CEO @ RayzeBio
President & CEO
2020-06-01
Deborah Charych Scientific Founder, Chief Technology Officer, Advisor @ RayzeBio
Scientific Founder, Chief Technology Officer, Advisor
2018-11-01
Nicholas Smith Senior Vice President, Chemistry Innovation @ RayzeBio
Senior Vice President, Chemistry Innovation
2021-07-01
Founder
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series C - RayzeBio
Logos Capital
Logos Capital investment in Series C - RayzeBio
OrbiMed
OrbiMed investment in Series C - RayzeBio
Redmile Group
Redmile Group investment in Series C - RayzeBio
LifeSci Venture Partners
LifeSci Venture Partners investment in Series C - RayzeBio
Samsara BioCapital
Samsara BioCapital investment in Series C - RayzeBio
Vivo Capital
Vivo Capital investment in Series C - RayzeBio
venBio Partners
venBio Partners investment in Series C - RayzeBio
Deerfield
Deerfield investment in Series C - RayzeBio
Versant Ventures
Versant Ventures investment in Series C - RayzeBio
Key Employee Changes
Official Site Inspections
http://www.rayzebio.com Semrush global rank: 2.82 M Semrush visits lastest month: 5.74 K
- Host name: 45.60.150.161
- IP address: 45.60.150.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RayzeBio"
Leadership Team - RayzeBio
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you …See details»
Front Page - RayzeBio
We are a vertically integrated radiopharmaceutical therapeutics (RPT) company focused on improving cancer patient survival by efficiently developing targeted innovative drugs that harness the power of radioisotopes. Explore our pipeline …See details»
RayzeBio - Crunchbase Company Profile & Funding
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in …See details»
RayzeBio Company Profile | Management and Employees List
RayzeBio Profile and History RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a …See details»
RayzeBio - Funding, Financials, Valuation & Investors - Crunchbase
RayzeBio is registered under the ticker NASDAQ:RYZB . Their stock opened with $18.00 in its Sep 15, 2023 IPO. Stock Symbol NASDAQ:RYZB ; Valuation at IPO $1B; Money Raised at …See details»
RayzeBio Overview | SignalHire Company Profile
To connect with RayzeBio employee register on SignalHire. Organization Website. rayzebio.com . Social Links. Phone Number (619)937-2754. RayzeBio industries. Biotech, Biotechnology, …See details»
Bristol Myers Squibb Completes Acquisition of …
Feb 26, 2024 Adds RYZ101, an IND Engine and Manufacturing Capability, to BMS Bristol Myers Squibb (NYSE: BMY) announced today that it has successfully completed its acquisition of RayzeBio, Inc. (NASDAQ: RYZB). With the …See details»
Rayzebio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Rayzebio, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 135 news, and 4 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic …See details»
RayzeBio, Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for RayzeBio, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
RayzeBio - BioSpace
Nov 18, 2024 RayzeBio operates as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology …See details»
Matthew (Matt) H. - Director, Health Physics - RayzeBio - LinkedIn
RayzeBio Apr 2023 - Present 1 year 11 months. Indianapolis, Indiana, United States Recommendations received ... De-risk your organization and protect your people and …See details»
RayzeBio Propels Forward with $418 Million Raised Since …
Sep 13, 2022 RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically …See details»
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform …
Dec 26, 2023 “Acquiring RayzeBio’s differentiated actinium-based radiopharmaceutical platform will establish Bristol Myers Squibb’s presence in one of the most promising and fastest …See details»
Putting Your Skills and Passion to Work at BMS: RayzeBio in San …
Mar 26, 2025 When he joined RayzeBio in August 2024, Chris brought a diverse range of experience that included five years in the Navy. “During our first deployment I found my …See details»
RayzeBio - Overview, News & Similar companies | ZoomInfo.com
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its previously …See details»
RayzeBio Inc.: Business Model, SWOT Analysis, and Competitors …
Jun 16, 2024 RayzeBio Inc. is known for developing innovative diagnostic and therapeutic solutions, primarily focusing on oncology. 2. What are the primary revenue streams for …See details»
RayzeBio - Work in biotech
RayzeBio is developing radiopharmaceuticals for cancer treatment. Radiopharmaceutical therapy (RPT) represents a promising novel approach to treat solid tumors. RPT works by selectively …See details»
Mitch Fletcher | Fletcher Organization, Inc. | President - Dun
View the business profile and contact info for Mitch Fletcher, President at Fletcher Organization, Inc. in California, US. Dynamic search and list-building capabilities; Real-time trigger alerts; …See details»
RayzeBio debuts with $45M to target tumors with …
Oct 14, 2020 RayzeBio Wednesday announced a $45 million series A financing, backed by lead investors VenBio Partners and Versant Ventures and joined by Samsara BioCapital, to …See details»
The Torsiello Organization | Home
2163 Oak Tree Road Suite 101. Edison, New Jersey 08820See details»